Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):245–251. doi: 10.1097/QAI.0000000000002142

TABLE 1.

Characteristics of Patients and Viral Load Tests Included in the Analysis, Patient-Centered HIV Care Model, 2014–2016, United States

Characteristic Total
Patient characteristics, n = 570
Median age (years [IQR]) 49 (40–57)
Median no. of viral load tests (IQR) 4 (2–6)
Characteristic, n (%)
Age (yrs)
 <50 268 (47)
 ≥50 302 (53)
Race/Ethnicity
 Black, non-Hispanic 231 (41)
 All other/unknown 339 (59)
Sex
 Male 444 (78)
 Female 126 (22)
Medical insurance
 Private insurance 83 (15)
 Nonprivate insurance 487 (85)
Viral load test characteristics, n = 2427*
PDC category, n (%)
 <50% 202 (8)
 50% to <80% 277 (11)
 80% to <85% 162 (7)
 85% to <90% 173 (7)
 ≥90% 1613 (67)
Viral load test results, n (%)
 <200 copies/mL 2180 (90)
 ≥200 copies/mL 247 (10)
ARV regimen category, n (%)
 INSTI-based 756 (31)
 NNRTI-based 513 (21)
 PI-Based 427 (18)
 All other 731 (30)
  INSTI-NRTI(2)-PI§ 122 (17)
  INSTI -NNRTI-PI§ 79 (11)
  INSTI -PI§ 65 (9)
  INSTI -NNRTI-NRTI(2)§ 53 (7)
  NRTI(2)-PI(2)§ 43 (6)
  NNRTI-NRTI(2)-PI§ 41 (6)
  INSTI -NNRTI-NRTI§ 40 (6)
*

Viral load tests with PDC values and included in the analysis, including the coinciding PDC category, viral load test value, and the coinciding primary ARV regimen.

INSTI-, NNRTI-, and PI-based regimens each included one medication of the main component and 2 nucleoside reverse transcriptase inhibitors (NRTI) as the “backbone” of the therapy.

“All other” category includes all regimens not categorized as an INSTI-, NNRTI-, or PI-based regimen.

§

The most common regimens within the “all other” category. The parentheses indicate the number of medication types within the regimen.